Join the club for FREE to access the whole archive and other member benefits.

Ben Gibson

Co-founder and CEO of Pano Therapeutics

Ben is a recovering investment banker turned entrepreneur focused on addressing the biggest problems in human health, in terms of individual health and resilience as well as global health. This ambition led Ben to a focus on mitochondrial biology as the central mediator of adaptive stress response (allostasis), and on the emerging paradigm of the mitochondrial etiology of complex diseases of aging to present both non-pharmacological and pharmacological interventions for health optimization and treatment of disease. Ben joined Pano Therapeutics, Inc. as Co-founder & CEO in 2019.

Visit website:


See also: Company Pano Therapeutics - Addressing complex diseases of aging by targeting mitochondrial ion channels and transporters.

Ben Gibson is also referenced in the following:

Metabesity 2021

11-Oct-2021 to 14-Oct-2021

The Kitalys institute virtual conference targeting key questions that will impact the future of aging and extending healthspan